Quick answer

Indica and sativa labels do not predict relief for back pain or inflammation. The words describe plant shape, leaf width, and growing origin. They do not describe chemistry. Two plants with the same label can hold different amounts of THC, CBD, and terpenes. Dose, route, and batch test results matter more than the label.

read more

What the labels mean

Sativa plants grow tall and narrow. Indica plants grow short and bushy. Growers used the terms in the 1970s. The rule that indica sedates and sativa energizes comes from that era. Lab tests show a weak link between label type and chemical profile. One 2021 analysis of commercial flower samples found that label type explained little of the variation in THC, CBD, and terpene content.

read more

Evidence for back pain

A 2017 National Academies report reviewed more than 10,000 studies. It found substantial evidence that cannabis or cannabinoids reduce chronic pain in adults. The report covered mixed pain types, including neuropathic pain. It did not isolate back pain.

related article

A 2015 JAMA meta-analysis pooled 79 trials and about 6,500 patients. It found moderate evidence for cannabinoids in chronic pain. The average effect was modest.

Sativa vs Indica for Pain: Which One to Buy First

No large trial compares indica against sativa for back pain. That study does not exist in the published record.

Inflammation

THC binds CB1 and CB2 receptors. CB2 receptors sit on immune cells. Cell and animal studies show that cannabinoids can lower cytokines such as TNF-alpha and IL-6. Human data for inflammatory back pain is thin. Most human trials measure pain scores, not inflammatory markers.

CBD binds CB1 and CB2 with low affinity. Researchers propose indirect paths, including FAAH inhibition and adenosine signaling. Most of that work is in cells and rodents.

Terpenes

Beta-caryophyllene binds CB2 in lab assays. Myrcene, limonene, and linalool appear in both labeled types. Terpene levels in a product depend on genetics, harvest date, and storage. A certificate of analysis lists them.

Dose and route

Inhaled THC reaches peak blood levels in minutes. Oral THC peaks in 1 to 3 hours and lasts longer. Edibles cause more overdose reports than flower. Start low with oral products. A common starting dose is 2.5 mg THC. High-CBD products with low THC carry less impairment risk.

Risks

THC can cause anxiety, dry mouth, and impaired coordination. It impairs driving. Heavy use links to cannabis use disorder. CBD can raise liver enzymes and interact with blood thinners. The FDA has not approved cannabis flower for pain. Epidiolex is the only approved CBD drug, and it treats seizures.

What to check on a label

Bottom line

Pick a product by THC and CBD ratio, not by indica or sativa. For daytime back pain, a low-THC, high-CBD product has less sedation risk. For night pain, a higher THC product may help sleep. Track dose, strain name, and effect in a log for 2 to 4 weeks.